Table 2.

Summary of common off-label use medications during ICU.

Off-label use of medications during ICU	All patients (N = 560)
Systemic corticosteroids, n (%)	473 (84.5)
Tocilizumab, n (%)	218 (38.9)
Anticoagulation treatment dose, n (%)	169 (30.2)
Oseltamivir, n (%)	162 (28.9)
Azithromycin, n (%)	139 (24.8)
Ascorbic acid, n (%)	121 (21.6)
Statins, n (%)	107 (19.1)
Zinc, n (%)	103 (18.4)
Aspirin, n (%)	81 (14.5)
Thiamine, n (%)	58 (10.4)
Hydroxychloroquine, n (%)	42 (7.5)
Lopinavir & Ritonavir, n (%)	34 (6.1)
Favipiravir, n (%)	11 (2.0)

Denominator of the percentage is the total number of patients.